Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer
BackgroundBone is a common target of metastasis in kidney cancer, and accurately predicting the risk of bone metastases (BMs) facilitates risk stratification and precision medicine in kidney cancer.MethodsPatients diagnosed with kidney cancer were extracted from the Surveillance, Epidemiology, and E...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/131e0da47be742b3ad480754d20df11d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:131e0da47be742b3ad480754d20df11d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:131e0da47be742b3ad480754d20df11d2021-12-01T01:28:03ZDevelopment and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer2234-943X10.3389/fonc.2021.731905https://doaj.org/article/131e0da47be742b3ad480754d20df11d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.731905/fullhttps://doaj.org/toc/2234-943XBackgroundBone is a common target of metastasis in kidney cancer, and accurately predicting the risk of bone metastases (BMs) facilitates risk stratification and precision medicine in kidney cancer.MethodsPatients diagnosed with kidney cancer were extracted from the Surveillance, Epidemiology, and End Results (SEER) database to comprise the training group from 2010 to 2017, and the validation group was drawn from our academic medical center. Univariate and multivariate logistic regression analyses explored the statistical relationships between the included variables and BM. Statistically significant risk factors were applied to develop a nomogram. Calibration plots, receiver operating characteristic (ROC) curves, probability density functions (PDF), and clinical utility curves (CUC) were used to verify the predictive performance. Kaplan-Meier (KM) curves demonstrated survival differences between two subgroups of kidney cancer with and without BMs. A convenient web calculator was provided for users via “shiny” package.ResultsA total of 43,503 patients were recruited in this study, of which 42,650 were training group cases and 853 validation group cases. The variables included in the nomogram were sex, pathological grade, T-stage, N-stage, sequence number, brain metastases, liver metastasis, pulmonary metastasis, histological type, primary site, and laterality. The calibration plots confirmed good agreement between the prediction model and the actual results. The area under the curve (AUC) values in the training and validation groups were 0.952 (95% CI, 0.950–0.954) and 0.836 (95% CI, 0.809–0.860), respectively. Based on CUC, we recommend a threshold probability of 5% to guide the diagnosis of BMs.ConclusionsThe comprehensive predictive tool consisting of nomogram and web calculator contributes to risk stratification which helped clinicians identify high-risk cases and provide personalized treatment options.Shengtao DongShengtao DongHua YangZhi-Ri TangYuqi KeHaosheng WangWenle LiWenle LiKang TianFrontiers Media S.A.articlerenal cell carcinomabone metastasisnomogramweb calculatorpredictive modelNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
renal cell carcinoma bone metastasis nomogram web calculator predictive model Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
renal cell carcinoma bone metastasis nomogram web calculator predictive model Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Shengtao Dong Shengtao Dong Hua Yang Zhi-Ri Tang Yuqi Ke Haosheng Wang Wenle Li Wenle Li Kang Tian Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer |
description |
BackgroundBone is a common target of metastasis in kidney cancer, and accurately predicting the risk of bone metastases (BMs) facilitates risk stratification and precision medicine in kidney cancer.MethodsPatients diagnosed with kidney cancer were extracted from the Surveillance, Epidemiology, and End Results (SEER) database to comprise the training group from 2010 to 2017, and the validation group was drawn from our academic medical center. Univariate and multivariate logistic regression analyses explored the statistical relationships between the included variables and BM. Statistically significant risk factors were applied to develop a nomogram. Calibration plots, receiver operating characteristic (ROC) curves, probability density functions (PDF), and clinical utility curves (CUC) were used to verify the predictive performance. Kaplan-Meier (KM) curves demonstrated survival differences between two subgroups of kidney cancer with and without BMs. A convenient web calculator was provided for users via “shiny” package.ResultsA total of 43,503 patients were recruited in this study, of which 42,650 were training group cases and 853 validation group cases. The variables included in the nomogram were sex, pathological grade, T-stage, N-stage, sequence number, brain metastases, liver metastasis, pulmonary metastasis, histological type, primary site, and laterality. The calibration plots confirmed good agreement between the prediction model and the actual results. The area under the curve (AUC) values in the training and validation groups were 0.952 (95% CI, 0.950–0.954) and 0.836 (95% CI, 0.809–0.860), respectively. Based on CUC, we recommend a threshold probability of 5% to guide the diagnosis of BMs.ConclusionsThe comprehensive predictive tool consisting of nomogram and web calculator contributes to risk stratification which helped clinicians identify high-risk cases and provide personalized treatment options. |
format |
article |
author |
Shengtao Dong Shengtao Dong Hua Yang Zhi-Ri Tang Yuqi Ke Haosheng Wang Wenle Li Wenle Li Kang Tian |
author_facet |
Shengtao Dong Shengtao Dong Hua Yang Zhi-Ri Tang Yuqi Ke Haosheng Wang Wenle Li Wenle Li Kang Tian |
author_sort |
Shengtao Dong |
title |
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer |
title_short |
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer |
title_full |
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer |
title_fullStr |
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer |
title_full_unstemmed |
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer |
title_sort |
development and validation of a predictive model to evaluate the risk of bone metastasis in kidney cancer |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/131e0da47be742b3ad480754d20df11d |
work_keys_str_mv |
AT shengtaodong developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT shengtaodong developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT huayang developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT zhiritang developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT yuqike developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT haoshengwang developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT wenleli developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT wenleli developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer AT kangtian developmentandvalidationofapredictivemodeltoevaluatetheriskofbonemetastasisinkidneycancer |
_version_ |
1718405945027985408 |